MARKET

STIM

STIM

Neuronetics
NASDAQ
1.290
-0.170
-11.64%
After Hours: 1.300 +0.01 +0.78% 19:59 06/05 EDT
OPEN
1.440
PREV CLOSE
1.460
HIGH
1.453
LOW
1.250
VOLUME
2.01M
TURNOVER
--
52 WEEK HIGH
4.850
52 WEEK LOW
0.8000
MARKET CAP
89.77M
P/E (TTM)
-2.3605
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STIM last week (0601-0605)?
Weekly Report · 4h ago
Neuronetics names Robert Greene senior vice president of sales
PUBT · 5d ago
NEURONETICS APPOINTS ROBERT GREENE AS SENIOR VICE PRESIDENT SALES
Reuters · 5d ago
Neuronetics spotlights real-world NeuroStar TMS outcomes data at Clinical TMS Society meeting
PUBT · 6d ago
Weekly Report: what happened at STIM last week (0525-0529)?
Weekly Report · 06/01 09:54
Neuronetics Shareholders Approve Directors, Auditor and Equity Plan
TipRanks · 05/29 22:21
Weekly Report: what happened at STIM last week (0518-0522)?
Weekly Report · 05/25 09:57
Neuronetics Extends Interim Financial Leadership Through Amended Agreement
TipRanks · 05/22 11:59
More
About STIM
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.

Webull offers Neuronetics Inc stock information, including NASDAQ: STIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STIM stock methods without spending real money on the virtual paper trading platform.